Yes, calcium channel blocker (CCB) ointments are effective for treating anal fissures and should be used as first-line medical therapy after conservative measures fail.
Topical CCB ointments are as effective as nitroglycerin for healing anal fissures but cause significantly fewer side effects, making them the preferred topical medical therapy. 1
Treatment Algorithm
First-Line: Conservative Care
Start all patients (especially acute fissures) with:
- Fiber supplementation
- Adequate fluid intake
- Sitz baths
- Topical analgesics
Approximately 50% of fissures heal with conservative care alone. 1
Second-Line: Topical CCB Therapy
If conservative care fails or symptoms are severe, topical CCB ointments are an acceptable and effective option 1:
- Healing rates: 52-95% depending on formulation and study 2, 3, 4
- Mechanism: Reversibly decreases resting anal pressure, promoting healing without permanent sphincter damage 1
- Side effects: Significantly fewer than nitroglycerin (particularly fewer headaches) 1, 5
Specific CCB Formulations with Evidence:
Nifedipine 0.3% + Lidocaine 1.5% ointment:
- 94.5% healing rate at 6 weeks 2
- Reduces mean anal resting pressure by 11% 2
- Recurrence in only 5.8% of healed patients 2
- No systemic side effects reported 2
- This combination is particularly effective 5, 2
Diltiazem 2% ointment:
- 75% healing rate initially, with additional patients healing after extended treatment 3
- Minimal side effects (perianal dermatitis in 6%, headaches in 1.4%) 3
- Recurrences respond well to repeat treatment 3
Comparison to Other Medical Therapies
CCBs vs. Nitroglycerin (GTN):
- Similar efficacy (CCBs may be slightly better) 1, 4
- Significantly fewer side effects with CCBs 1, 6
- Better patient compliance due to tolerability 7
Topical vs. Oral CCBs:
- Topical formulations are superior: 21.3% failure rate vs. 38.4% with oral 6
- Topical CCBs have significantly fewer side effects (4.3% vs. 38%) 6
- No difference in recurrence rates 6
Third-Line: Surgical Options
Reserve lateral internal sphincterotomy (LIS) for:
- Failed medical therapy
- Intolerable pain requiring immediate intervention
- Patient preference after informed discussion
LIS has 95% healing rates but carries risk of permanent minor incontinence 4.
Important Caveats
Commercial availability issue: The AGA guideline notes that appropriately diluted topical CCB preparations were not commercially available in the United States as of 2003 1. However, compounding pharmacies can prepare these formulations, and some formulations may now be available depending on your region 5.
Long-term outcomes: While initial healing rates are excellent, long-term failure rates with topical therapy require monitoring 1. Recurrences typically respond to repeat courses of treatment 2, 3.
Off-midline fissures: Always evaluate for underlying conditions (Crohn's disease, HIV/AIDS, tuberculosis, malignancy) when fissures occur off the posterior midline 1.
Clinical Reasoning
The evidence strongly supports topical CCBs as an intermediate option that combines the safety of conservative therapy with effectiveness approaching surgical intervention. They achieve prompt but temporary sphincter relaxation without the permanent continence risks of surgery 1. Recent trends favor CCBs over nitroglycerin as first-line pharmacologic therapy 7, 8.